Fig. 2From: The use of eculizumab in gemcitabine induced thrombotic microangiopathya Demonstration of serum creatinine levels in relation to time since initiation of gemcitabine therapy and different interventions. b Demonstration of platelets level in relation to time since initiation of gemcitabine therapy and different interventions. c Demonstration of LDH level in relation to time since initiation of gemcitabine therapy and different interventions. HD – hemodialysisBack to article page